“Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Nonvalvular Atrial Fibrillation – in-Group Comparison”. 2022. Prospects in Pharmaceutical Sciences 20 (1): 26-31. https://doi.org/10.56782/pps.36.